Revolution Medicines (RevMed) is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

RevMed is seeking an accomplished and highly strategic patent attorney to lead intellectual property strategy for our patent portfolio. This role is designed for a senior expert who can operate at the intersection of sophisticated patent prosecution and patent disputes within one of the most competitive areas in oncology.

Reporting to the VP of IP, this individual will serve as the patent portfolio lead, with responsibility for developing and integrating global prosecution and challenge (bot...